Biologics Financial Theradaptive Appoints Daniel Wolf as Chief Financial Officer, Continuing Executive Transformation byTim AllenApril 22, 2025
Financial Spine Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis byTim AllenApril 21, 2025
Extremities Financial Top Stories Zimmer Biomet Completes Acquisition of Paragon 28 byBree MillerApril 21, 2025
Financial Amplitude Surgical – 9-Months Consolidated Sales for FY 2024-25 of €83.8m, up +6.4% at Constant Exchange Rates byTim AllenApril 18, 2025
Financial Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% byJosh SandbergApril 16, 2025
Financial SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales byTim AllenApril 16, 2025
Financial Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025 byTim AllenApril 15, 2025
Financial Minimally Invasive Surgical Devices Patent Landscape Report 2025, with Intuitive Surgical, LSI Solutions, Tendyne Holdings, Ethicon Endo Surgery and Invuity byTim AllenApril 14, 2025
Financial ATEC to Report First Quarter 2025 Financial Results on May 1, 2025 byJosh SandbergApril 14, 2025